Natural Cycles, a women’s health company behind the world’s first birth control app, has closed a $55 million Series C financing round led by Lauxera Capital Partners. The funding round also saw participation from Point72 Private Investments and a revolving debt facility from J.P. Morgan. The new capital will be used for commercial acceleration, new product development, and healthcare reimbursement automation.
Advancing digital birth control solutions
Founded in 2013 by Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Stockholm headquartered- Natural Cycles is a pioneering women’s digital health company that developed the world’s first birth control app. This direct-to-consumer contraceptive app has been used by over three million users globally and remains the only digital form of birth control cleared by regulators in the United States (FDA), Europe (TÜV SÜD), Canada (Health Canada), Australia (TGA), Singapore (HSA), and South Korea (MFDS).
The NC° app, a certified medical device, is powered by an algorithm that uses body temperature to determine daily fertility status. Users can manually take their temperature with a thermometer or sync overnight temperature data from an Oura Ring or Apple Watch. The app is approved for use as a contraceptive in the United States, the UK, Canada, Australia, Singapore, and South Korea.
Dr Raoul Scherwitzl, co-founder and CEO of Natural Cycles, expressed his excitement about the new phase in the company’s journey: “We’ve experienced profitable growth over the last few years as women actively seek more birth control options, and we’re excited to welcome the next phase of Natural Cycles’ journey together with Lauxera Capital Partners and Point72 Private Investments. We look forward to leveraging their expertise to fulfil Natural Cycles’ mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of women’s health.”
Expanding product offerings and global reach
Earlier this month, Natural Cycles launched NC° Postpartum, a new feature within the app designed to support new mothers in their physical and mental recovery from childbirth. NC° Postpartum complements the three existing modes available in the app—NC° Birth Control, NC° Plan Pregnancy, and NC° Follow Pregnancy—offering comprehensive support throughout the fertility journey.
Samuel Levy, founding partner of Lauxera Capital Partners, highlighted the strategic partnership: “Our mission at Lauxera is to partner with ambitious entrepreneurs transforming the future of medicine with unique technology. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats. We are delighted to partner with Elina, Raoul, and their team to offer women an alternative to traditional approaches without the side effects and compromises.”
As part of the investment, Samuel Levy will join Natural Cycles’ Board of Directors.
Distinguished investors and future prospects
Lauxera Capital Partners and Point72 Private Investments join Natural Cycles’ existing investors, which include EQT Ventures, Samsung Ventures, Heartcore Capital, Headline, and Bonnier Ventures. The combined support from these investors will propel Natural Cycles towards expanding its market presence and developing innovative solutions in women’s health.
